• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'.乳腺癌护理中对治疗指南的遵循——“妇科肿瘤学工作小组乳腺组”的回顾性分析
Breast Care (Basel). 2008;3(2):87-92. doi: 10.1159/000127434. Epub 2008 Apr 25.
2
[Breast cancer: analysis of treatment quality in Germany 2004: retrospective survey by Arbeitsgemeinschaft Gynäkologische Onkologie (AGO)].[乳腺癌:2004年德国治疗质量分析:妇科肿瘤协作组(AGO)的回顾性调查]
Zentralbl Gynakol. 2006 Dec;128(6):352-61. doi: 10.1055/s-2006-955230.
3
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.妇科肿瘤协作组《早期乳腺癌患者诊断与治疗建议:2024年更新》
Breast Care (Basel). 2024 Jun;19(3):165-182. doi: 10.1159/000538596. Epub 2024 Apr 18.
4
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023.妇科肿瘤学工作组:早期乳腺癌患者的诊断和治疗建议:2023年更新
Breast Care (Basel). 2023 Aug;18(4):289-305. doi: 10.1159/000531578. Epub 2023 Jun 16.
5
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024.妇科肿瘤学工作组:局部晚期和转移性乳腺癌患者的诊断和治疗建议:2024年更新
Breast Care (Basel). 2024 Jun;19(3):183-191. doi: 10.1159/000538753. Epub 2024 Apr 10.
6
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference.早期乳腺癌全身治疗的观念转变:德国专家对第17届圣加仑国际共识会议的看法
Breast Care (Basel). 2022 Jun;17(3):336-345. doi: 10.1159/000517501. Epub 2022 Apr 8.
7
ABC7 Consensus: Assessment by a German Group of Experts.ABC7共识:德国专家小组的评估
Breast Care (Basel). 2024 Apr;19(2):116-128. doi: 10.1159/000535997. Epub 2024 Jan 24.
8
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023.AGO关于局部晚期和转移性乳腺癌患者诊断与治疗的建议:2023年更新版
Breast Care (Basel). 2023 Aug;18(4):306-315. doi: 10.1159/000531579. Epub 2023 Jun 16.
9
Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.卡铂/紫杉醇与顺铂/紫杉醇作为晚期卵巢癌一线化疗方案的比较:妇科肿瘤学 Arbeitsgemeinschaft 卵巢癌研究组一项随机 III 期试验的中期分析
Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-44-S15-52.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

1
Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancer.转移性激素受体阳性、人表皮生长因子受体2阴性乳腺癌一线全身治疗的序贯偏好
Front Oncol. 2023 Oct 18;13:1181375. doi: 10.3389/fonc.2023.1181375. eCollection 2023.
2
Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study.在德国常规护理中,对 1650 例早期乳腺癌患者进行辅助化疗治疗:来自前瞻性 TMK 队列研究的数据。
Breast Cancer. 2018 May;25(3):275-283. doi: 10.1007/s12282-017-0823-7. Epub 2017 Dec 4.
3
Disease Management Project Breast Cancer in Hesse - 5-Year Survival Data: Successful Model of Intersectoral Communication for Quality Assurance.黑森州乳腺癌疾病管理项目——5年生存数据:质量保证跨部门沟通的成功模式
Geburtshilfe Frauenheilkd. 2014 Mar;74(3):276-283. doi: 10.1055/s-0034-1368169.
4
The Impact of Breast Care Nurses on Patients' Satisfaction, Understanding of the Disease, and Adherence to Adjuvant Endocrine Therapy.
Breast Care (Basel). 2011;6(3):221-226. doi: 10.1159/000329006. Epub 2011 Jun 3.
5
Bendamustine in Metastatic Breast Cancer: An Old Drug in New Design.苯达莫司汀治疗转移性乳腺癌:旧药新用。
Breast Care (Basel). 2008;3(5):333-339. doi: 10.1159/000154105. Epub 2008 Oct 16.
6
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer.多中心观察性试验:聚乙二醇脂质体阿霉素治疗转移性乳腺癌。
BMC Cancer. 2010 Jan 5;10:2. doi: 10.1186/1471-2407-10-2.

本文引用的文献

1
Impact of chemotherapy beyond the first line in patients with metastatic breast cancer.转移性乳腺癌患者一线治疗后化疗的影响。
Breast Cancer Res Treat. 2008 Jan;107(2):275-9. doi: 10.1007/s10549-007-9550-7. Epub 2007 Mar 23.
2
Evidence-based treatment of metastatic breast cancer - 2006 recommendations by the AGO Breast Commission.
Eur J Cancer. 2006 Nov;42(17):2897-908. doi: 10.1016/j.ejca.2006.06.033.
3
Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment.六项欧洲乳腺癌治疗审计中的中性粒细胞减少事件风险与化疗给药障碍
Support Care Cancer. 2006 Sep;14(9):901-9. doi: 10.1007/s00520-006-0034-9. Epub 2006 Apr 19.
4
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.国际专家小组关于可手术乳腺癌新辅助(原发性)全身治疗应用的建议:更新版
J Clin Oncol. 2006 Apr 20;24(12):1940-9. doi: 10.1200/JCO.2005.02.6187.
5
Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer.卵巢癌的治疗模式以及参与临床研究对其预后的影响。
Int J Gynecol Cancer. 2005 Mar-Apr;15(2):183-91. doi: 10.1111/j.1525-1438.2005.15202.x.
6
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.老年和年轻淋巴结阳性乳腺癌女性的辅助化疗
JAMA. 2005 Mar 2;293(9):1073-81. doi: 10.1001/jama.293.9.1073.
7
Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer.遵循全身治疗的共识性建议与淋巴结阴性乳腺癌女性患者生存率的提高相关。
J Clin Oncol. 2004 Sep 15;22(18):3685-93. doi: 10.1200/JCO.2004.07.018. Epub 2004 Aug 2.
8
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.会议亮点:早期乳腺癌主要治疗方法的最新国际专家共识。
J Clin Oncol. 2003 Sep 1;21(17):3357-65. doi: 10.1200/JCO.2003.04.576. Epub 2003 Jul 7.
9
[Evidence-based recommendations on primary treatment of carcinomas of the breast].
Zentralbl Gynakol. 2002 May;124(5):293-303. doi: 10.1055/s-2002-34095.

乳腺癌护理中对治疗指南的遵循——“妇科肿瘤学工作小组乳腺组”的回顾性分析

Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'.

作者信息

Jackisch Christian, Untch Michael, Chatsiproios Dimitrios, Lamparter Christiane, Overkamp Friedrich, Lichtenegger Werner, Rönsberg Wolfgang, Thomssen Christoph, von Minckwitz Gunter, Albert Ute-Susann

机构信息

Clinic for Gynaecology and Obstetrics, Klinikum Offenbach GmbH.

出版信息

Breast Care (Basel). 2008;3(2):87-92. doi: 10.1159/000127434. Epub 2008 Apr 25.

DOI:10.1159/000127434
PMID:21373210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2931081/
Abstract

BACKGROUND

The Organgruppe Mamma of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) performed a nationwide 3-phase analysis of the structure of care and standard of therapy given to patients with breast cancer from 2002 (4th quarter) to 2004 (4th quarter). The extent to which national and international treatment recommendations are implemented in routine clinical practice had so far not been evaluated in an interdisciplinary approach. No reliable data on the pattern of care of these patients have been published in Germany before. PATIENTS AND METHODS: The project included early breast cancer in the adjuvant and neoadjuvant setting as well as metastatic disease. We present the results of phase III of the AGO analysis, which are based on a survey conducted by the Organkommission Mamma in the 4th quarter of 2004. RESULTS: Evaluation of the data reveals that treatment based on the guidelines is now being implemented very reliably in certain sectors. This is of particular relevance to the pattern of adjuvant treatment in early breast cancer. In contrast, in metastatic breast cancer (MBC), the complexity of the interdisciplinary treatment approach is complicating this kind of straightforward analysis. CONCLUSION: The present analysis conducted by the AGO was the first attempt to analyse the treatment provided in patients presenting with MBC in a systematic fashion. The fundamental problem remains, irrespective of the stage of the tumour, that too few patients are treated in randomised clinical trials. The mission set by the AGO-Organkommission Mamma is the longitudinal observation of the therapy practices for breast cancer on the basis of the observations discussed here, which should ultimately benefit the optimisation of therapy quality in Germany.

摘要

背景

德国妇科肿瘤协作组(AGO)的乳腺癌工作组对2002年(第四季度)至2004年(第四季度)期间乳腺癌患者的护理结构和治疗标准进行了一项全国性的三阶段分析。此前尚未采用跨学科方法评估国家和国际治疗建议在常规临床实践中的实施程度。德国此前尚未发表过关于这些患者护理模式的可靠数据。

患者与方法

该项目包括辅助和新辅助治疗背景下的早期乳腺癌以及转移性疾病。我们展示了AGO分析第三阶段的结果,这些结果基于乳腺癌委员会在2004年第四季度进行的一项调查。

结果

数据评估显示,基于指南的治疗目前在某些领域得到了非常可靠的实施。这与早期乳腺癌的辅助治疗模式尤为相关。相比之下,在转移性乳腺癌(MBC)中,跨学科治疗方法的复杂性使这种直接分析变得复杂。

结论

AGO进行的本次分析是首次尝试系统分析MBC患者的治疗情况。无论肿瘤处于何种阶段,根本问题仍然是参与随机临床试验的患者太少。AGO乳腺癌委员会设定的任务是在此处讨论的观察结果基础上对乳腺癌治疗实践进行纵向观察,这最终应有助于德国治疗质量的优化。